Battling Exorbitance: High Costs in Sickle Cell Gene Therapies and the Imperative of Global Patient

Vineet Bhatt03 Nov, 2025Technology

The recent FDA approvals signify a breakthrough in sickle cell gene therapies, yet their high costs present formidable barriers to accessibility. This article highlights the vital role of global patient registries, stressing their importance in fostering inclusivity and efficiently organizing diverse data.